Got a stuffy nose and a cough? If you go to an urgent care or ER, chances are that you may be able find out exactly what type of germ is making you sick, thanks to newer tests that don’t look for just ...
Please provide your email address to receive an email when new articles are posted on . “Contrary to the initial intentions of the multiplex assay, our study demonstrates that the inherent advantages ...
Hologic is acquiring molecular diagnostics firm Mobidiag Oy in an approximately $795 million deal that will give the women’s health company the capability to offer testing closer to patients with ...
The "Molecular Diagnostics for Infectious Disease – Market Forecasts, Strategies and Trends – By Syndrome and by Country – With Multiplex and Point of Care Market Analysis, Executive Guides and ...
GlobalData on MSN
LEX Diagnostics secures FDA clearance for VELO PCR system
The system is intended for use in urgent care clinics, primary care settings, physician office laboratories, and pharmacies.
QIAGEN N.V. QGEN recently received Emergency Use Authorization (EUA) from the FDA for the NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Assay. Notably, the polymerase chain reaction (PCR) multiplex test will ...
Patient-Reported Outcome Results From the Open-Label Phase III AURELIA Trial Evaluating Bevacizumab-Containing Therapy for Platinum-Resistant Ovarian Cancer Although predictive multiplex somatic ...
The Canada Point of Care Molecular Diagnostics Market, valued at USD 350 million in 2024, is projected to reach USD 560 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results